Additionally, Cyp8b1 depletion prevented the progression of hepatic steatosis and caused its regression (28), suggesting that inhibiting CYP8B1 may reduce susceptibility to atherosclerosis as well as hepatic steatosis. The gene discussed is CYP8B1; the disease is fatty liver disease.